FOXP1

Research collaboration

Several groups in the world are currently studying FOXP1 patients:
Functional abilities from childhood to adulthood: the Netherlands (Leiden and Nijmegen)
Pathomechanism of FOXP1 mutations in iPS cells: the Netherlands (Leiden and Nijmegen)
Speech and language: Australia (Murdock) Autism and neurobehavioral features: New York (Seaver Institute)